Skip to main content

Growth Hormone Deficiency

Differential Diagnosis and Treatment

  • Chapter
Diseases of the Pituitary

Part of the book series: Contemporary Endocrinology ((COE,volume 3))

Abstract

Growth is a fundamental part of childhood and reflects the complex interactions of environmental, hormonal, and genetic factors. Assessment of growth is an essential component in monitoring childhood health and development. During the first few years of life, a child’s height can cross percentile lines on a growth chart, reflecting, at least in part, his or her genetic makeup. After this time, children grow in a relatively predictable manner and deviation from a normal growth pattern may reflect an underlying chronic disorder. Accurate growth measurements should therefore be a part of the routine pediatric examination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Whitehouse RH, Tanner JM, Healy MJR. Diurnal variation in stature and sitting height in 12-14 year old boys. Ann Hum Biol 1974; 1:103–106.

    Article  PubMed  CAS  Google Scholar 

  2. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Stanford University Press, Stanford, CA, 1959.

    Google Scholar 

  3. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40:423–441.

    Article  PubMed  CAS  Google Scholar 

  4. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64:51–58.

    Article  PubMed  CAS  Google Scholar 

  5. Carlsson LMS, Attie KM, Compton PG, et al. Reduced concentrations of serum GHBP in children with idiopathic short stature. J Clin Endocrinol Metab 1994; 78:1325–1330.

    Article  PubMed  CAS  Google Scholar 

  6. Salmon WD Jr, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957; 49:825–836.

    PubMed  CAS  Google Scholar 

  7. Rinderknecht E, Humbel RE. The amino sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978; 253:2769–2776.

    PubMed  CAS  Google Scholar 

  8. Rinderknecht E, Humbel RE. Primary structure of human insulin-like growth factor II. FEBS Lett 1978; 89:283-286.

    Article  PubMed  CAS  Google Scholar 

  9. Brissenden JE, Ullrich A, Francke U. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 1984; 310:781–784.

    Article  PubMed  CAS  Google Scholar 

  10. Tricoli JV, Rail LB, Scott J, et al. Localization of human insulin-like growth factor genes to human chromosomes 11 and 12. Nature 1984; 310:784–785.

    Article  PubMed  CAS  Google Scholar 

  11. Luna AM, Wilson DM, Wibbelsman CJ, et al. Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II Levels. J Clin Endocrinol Metab 1983; 57:258–271.

    Article  Google Scholar 

  12. Hintz RL, Liu F. A radioimmunoassay for insulin-like growth factor-II specific for the C-peptide region. J Clin Endocrinol Metab 1982; 54:442–446.

    Article  PubMed  CAS  Google Scholar 

  13. Massague J, Czech MP. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982; 257:5038–5045.

    PubMed  CAS  Google Scholar 

  14. Rosenfeld RG, Hintz RL. Somatomedin receptors: structure, function and regulation. In: Conn M, ed. The Receptors. Academic, New York, 1986; pp. 281–329.

    Google Scholar 

  15. MacDonald R, Pfeffer SR, Coussens L, et al. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 1988; 239:1134-1137.

    Article  PubMed  CAS  Google Scholar 

  16. Rosenfeld RG, Conover CA, Hodges D, et al. Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparisonm of natural, synthetic and recombinant DNA derived insulin-like growth factor I. Biochem Biophys Res Commum 1987; 143:195–205.

    Article  Google Scholar 

  17. Cohen P, Rosenfeld RG. Physiologic and clinical relevance of the insulin-like growth factor binding proteins (review). Cur Opinion Peds 1994; 6:462-467.

    Article  CAS  Google Scholar 

  18. Martin GL, Baxter RC. Insulin-like growth factor binding protein from human plasma. Purification and characterization. J Biol Chem 1986; 261:8754–8760.

    PubMed  CAS  Google Scholar 

  19. Baxter RC. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding howmone complex. J Clin Endocrinol Metab 1988; 67:265–272.

    Article  PubMed  CAS  Google Scholar 

  20. Spranger J. International classification of osteochondrodysplasias. Eur J Pediatr 1992; 151: 407-415.

    Article  PubMed  CAS  Google Scholar 

  21. Rivkees SA, Bode HH, Crawford JD. Long-term growth in juvenile acquired hypothyroidism. N Engl J Med 1988; 318:599–602.

    Article  PubMed  CAS  Google Scholar 

  22. Magiakou MA, Mastorakos G, Oldfield EH, et al. Cushing’s syndrome in children and adolescents. Presentation, diagnosis and therapy. N Engl J Med 1994; 331:629–636.

    Article  PubMed  CAS  Google Scholar 

  23. Katz HP, Youlton R, Kaplan SL, et al. Growth and growth hormone. III. Growth hormone release in children with primary hypothyroidism and thyrotoxicosis. J Clin Endocrinol Metab 1969; 29:346.

    Article  PubMed  CAS  Google Scholar 

  24. Fratz AG, Rabkin MT. Human growth hormone. Clinical measurement, response to hypoglycemia and suppression by corticosteroids. N Engl J Med 1964; 271:1375.

    Article  Google Scholar 

  25. Thompson RG, Rodriguez A, Kowarski A, et al. Growth hormone: metabolic clearance rates in normal adults and effect of prednisone. J Clin Invest 1972; 51:3193–3199.

    Article  PubMed  CAS  Google Scholar 

  26. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic Controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995; 80:1532–1540.

    Article  PubMed  CAS  Google Scholar 

  27. Reiter EO, Morris AH, MacGillivray MH, et al. Variable estimates of serum growth hormone concentrations by different radioassay systems. J Clin Endocrinol Metab 1988; 66:68–71.

    Article  PubMed  CAS  Google Scholar 

  28. Spiliotis BE, August GP, Hung W, et al. Growth neurosecretory dysfunction: a treatable cause of short stature. JAMA 1984; 252:2223–2230.

    Article  Google Scholar 

  29. Delier, Jr JJ, Boulis MW, Hariss WE, et al. Growth hormone response patterns to sex hormone administration in growth retardation. Am J Med Sci. 1970; 259:292–296.

    Article  Google Scholar 

  30. Marin G, Domene HM, Barnes KM, et al. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994; 79:537–541.

    Article  PubMed  CAS  Google Scholar 

  31. Underwood LE, D’Ercole AJ, Van Wyk JJ. Somatomedin-C and the assessment of growth. Pediatric Clin North Am. 1980; 27:771–782.

    CAS  Google Scholar 

  32. Rosenfeld RG, Wilson DM, Lee PDK, et al. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr. 1986; 109:428–433.

    Article  PubMed  CAS  Google Scholar 

  33. Magalam HJ, Albert VR, Ingraham HA, et al. A pituitary POU domain protein, pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 1989; 3:946–958.

    Article  Google Scholar 

  34. Pfaffle RW, DiMattia E, Parks JS, et al. Mutations of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257:1118–1121.

    Article  PubMed  CAS  Google Scholar 

  35. Rosenfeld RG, Northcraft GB, Hintz RL. A prospective, randomized trial of testosterone treatment of constitutional short stature in adolescent males. Pediatrics 1982; 69:681–687.

    PubMed  CAS  Google Scholar 

  36. Frasier SD. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocr Rev 1983;4:155–170.

    Article  PubMed  CAS  Google Scholar 

  37. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336:285–288.

    Article  PubMed  CAS  Google Scholar 

  38. Fradkin JE. Creutzfeldt-Jacob disease in pituitary growth hormone recipients. Endocrinologist 1993; 3:108–114.

    Article  Google Scholar 

  39. Hintz RL. Untoward events in patients treated with growth hormone in the USA. Horm Res 1992; 38(suppl 1):44–49.

    Article  PubMed  Google Scholar 

  40. Fisher DA, Job JC, Preece M, et al. Leukemia in patients treated with growth hormone. Lancet 1988; 1:1159–1160.

    Google Scholar 

  41. Guler HP, Schmid C, Zapf J, et al. Effects of recombinant insulin-like growth factor-I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 1989; 86:2868–2872.

    Article  PubMed  CAS  Google Scholar 

  42. Laron Z, Klinger B, Jensen JT, et al. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clin Endocrinol (Oxf) 1991; 35:145–150.

    Article  CAS  Google Scholar 

  43. Laron Z, Anin S, Klipper-Auerbach Y, et al. Effects of insulin-like growth factor-I on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 1992; 339:1258–1261.

    Article  PubMed  CAS  Google Scholar 

  44. Walker J, Van Wyk JJ, Underwood LE. Stimulation of statural growth by recombinant insulin-like growth factor-I in a child with growth hormone insensitivity syndrome (Laron type). J Pediatr 1992; 121:641–646.

    Article  PubMed  CAS  Google Scholar 

  45. Savage MO, Wilton P, Ranke MB, et al. Therapeutic response to recombinant IGF-I in thirty-two patients with growth hormone insensitivity. Pediatr Res 1993; 33:S5 (abstract).

    Article  Google Scholar 

  46. Guevara-Aguirre J, Vasconez O, Martinez V, et al. A randomized, doulbe-blind, placebo controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 1995; 80(4): 1393–1398.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Humana Press Inc.

About this chapter

Cite this chapter

Hunten, M.K., Rosenfeld, R.G. (1997). Growth Hormone Deficiency. In: Wierman, M.E. (eds) Diseases of the Pituitary. Contemporary Endocrinology, vol 3. Humana Press. https://doi.org/10.1007/978-1-4612-3954-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3954-3_6

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-8438-3

  • Online ISBN: 978-1-4612-3954-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics